Orkambi, a New Cystic Fibrosis Drug, Wins F.D.A. Approval
The drug is the second one brought to market by Vertex and could be effective for more patients than the first drug, Kalydeco.
Source: NYT Health - Category: Consumer Health News Authors: ANDREW POLLACK Tags: Cystic Fibrosis Drugs (Pharmaceuticals) Food and Drug Administration Vertex Pharmaceuticals Inc VRTX NASDAQ Biotechnology and Bioengineering Source Type: news